This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

Small-cap stocks outperformed the major indices Tuesday, once again on the power of positive news out of small health-care names like Advancis Pharmaceutical (AVNC).

Shares of the Maryland drugmaker surged 13.6% to $3.10 after the Food and Drug Administration accepted a resubmitted new-drug application for its proposed strep-throat treatment, Amoxicillin Pulsys. The FDA initially rejected the application in February, asking for more information on the company's planned manufacturing processes.

France-based Edap (EDAP - Get Report), a medical-equipment maker, jumped 14% to $6.84 after saying it will fast-track its ongoing U.S. clinical trial for Ablatherm-HIFU (high-intensity focused ultrasound), a proposed noninvasive treatment for prostate cancer. Meanwhile, Jeffries started coverage of RadNet (RDNT) with a buy rating. Shares of the Los Angeles-based company, a purveyor of magnetic-resonance imaging and other imaging services, climbed 10% to $6.54.

In earnings news, California's House of Taylor Jewelry (HOTJ) vaulted 18.3% to $2 after reporting sharply higher first-quarter revenue of $4.5 million, compared with $1.4 million a year ago. Its per-share loss was 2 cents wider at 8 cents, but this includes a far higher interest expense vs. last year.

Gambling Partners International (GPIC - Get Report) shares leapt 15.3% to $11.75 after the Las Vegas-based gambling-equipment maker reported a loss of just 18 cents a share. Analysts sought a 22-cent per-share loss.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
EDAP $3.38 0.30%
GPIC $10.02 -0.69%
STRM $2.36 -6.30%
AAPL $124.92 -0.86%
FB $86.72 -0.95%

Markets

DOW 17,649.01 -34.57 -0.20%
S&P 500 2,067.40 -1.36 -0.07%
NASDAQ 4,963.8630 -28.0770 -0.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs